Volastra Therapeutics to collaborate with Bristol Myers Squibb to develop new cancer drugs
Volastra Therapeutics, an oncology company focused on exploiting chromosomal instability (CIN) as a vulnerability for cancer cells, will collaborate with Bristol Myers Squibb to discover, develop and commercialize new medicines.